There are currently no events.
Cambridge Healthtech Institute - High Content Analysis 2009
Attended by over 400 delegates, with presentations by 60 speakers, 5 user-group meetings and 25 exhibits, this was the largest international conference on High Content Analysis. The conference provided opportunities for CellAura to meet directly with the scientists who want to use our products.
Select Biosciences - Screening, MedChem and ADMET Europe 2009
Attended by over 300 delegates, with presentations by 50 speakers, including "Fluorescent Approaches to Studying G Protein-Coupled Receptors" by Professor Stephen Hill, CellAura were able to present their products to scientists from a broad range of Pharma disciplines.
SBS - Bioassays and Technology Innovation 2009
Attended by over 1600 delegates, this was another very successful exhibition for CellAura. We presented two posters at the conference, one of them winning a 'Top 10 Posters' award. A complete power black-out at the conference venue, caused by protesting local energy company workers, was also capitalised on by CellAura using its luminescent glowstick giveaways to highlight its booth in the gloomy Exhibit Hall.
Science World - The Fisher Scientific Laboratory Experience 2009
Attended by Fisher Scientific customers from a broad spectrum of the life sciences (academic, industrial, teaching and research facilities), this was the first opportunity for CellAura to announce our new UK and Ireland Distributor Agreement with Fisher Scientific, and to meet Fisher Scientific customers in new markets.
SBS/ELRIG - Drug Discovery 2009
Attended by over 1000 delegates, the ELRIG/SBS/BPS Drug Discovery 2009 conference was probably the largest UK event for academic and industrial scientists involved in early-phase drug discovery. CellAura continues to generate interest in its pharmacologically validated fluorescent GPCR ligands, with several delegates enquiring about our speciality Custom Ligand Development service.
Chesterford Research Park GPCRs Conference 2009
CellAura were invited by MDS-Analytical Technologies to give a presentation at the MDS-AT / BioFocus DPI / DiscoveRx sponsored 'Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling' meeting. The presentation: 'Fluorescent Approaches to the Study of GPCRs' by Dr. Alison Carter (Pharmacologist at CellAura) was well received and generated lively discussion.
SBS - Advancing Drug Discovery 2010
During this five-day event, more than 2,000 scientists, innovators, researchers and industry analysts from around the world will converge in Phoenix to learn about the latest trends in basic and applied research that are transforming the way new pharmaceuticals are developed. CellAura will be promoting exciting new additions to its catalogue of fluorescent GPCR ligands at the meeting. Come and see us at booth # 721
EPIC - European Partnering and Investment Conference 2010
This event will be attended by some 250-300 delegates, who are a mixture of investors, big pharma and biotech companies looking to do business with European biotechnology businesses. CellAura will be presenting its exciting range of fluorescent GPCR ligand products as an enabling platform technology for Drug Discovery, and is seeking partners to co-develop new fluorescent GPCR ligands and other novel fluorescence-labelled products.
IBIZ Invest 2011
IBIZ provides a unique opportunity for international businesses and UK companies to identify new markets and forge new partnerships. CellAura will be presenting at the IBIZ Invest 2011 event to seek investment partners to support further cell-based screening product and technology development.
ELRIG - Advances in Cell Based Screening Technologies
At this conference we will hear talks on the latest cutting edge detection technologies and biological techniques transitioning into screening labs. CellAura will be attending the ELRIG “Advances in Cell-Based Screening Technologies” meeting to promote its portfolio of fluorescent ligands for live cell imaging and high content screening, and to keep up-to-date with the changing landscape of Cell-Based screening technologies.
BioTrinity 2011 will bring together investors, global phama and innovative biotech and medtech R&D companies under one roof. CellAura will be arranging partnering meetings at BioTrinity 2011 to seek investment partners to support further cell-based screening product and technology development.
ELRIG-SLAS-BPS - Drug Discovery 2011
ELRIG (European Laboratory and Robotics Interest Group), SLAS the (Society for Laboratory Automation and Screening) and BPS (British Pharmacological Society) are now preparing for the Fifth Annual Drug Discovery Conference to be held at Manchester Central on 7th & 8th September 2011. CellAura will be attending the meeting to participate in the GPCR Drug Discovery session and to launch new products in its portfolio of fluorescent ligands for live cell imaging and high content screening.
BMG User Group Meeting 2011
Cell based, biologically relevant assays are advancing at an unprecedented rate and their robustness is becoming more essential to everyone working in this field. BMG LABTECH are running a User Group meeting focussed on novel cell based assay technologies. CellAura will be giving a presentation titled: Fluorescent GPCR Ligands in Live Cell Assays: From High Content Analysis to High Throughput Screening. If you are currently performing cell based assays or planning a new project in this field, join us for an afternoon of interesting presentations highlighting new and innovative methods.
CellAura User Group Workshop
CellAura will be holding its inaugural Fluorescent Ligands User Group Workshop as a follow-on after the British Pharmacological Society 4th Focused Meeting on Cell Signalling. Please contact firstname.lastname@example.org to register for the event.